<?xml version="1.0" encoding="UTF-8"?>
<study xmlns="gme://ccts.cabig/1.0/
gov.nih.nci.cabig.ccts.domain"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:c3pr="gme://ccts.cabig/1.0/gov.nih.nci.cabig.ccts.domain"
    gridId="774e1520-17c6-4260-a092-b952b5919ab5">
    <blindedIndicator>true</blindedIndicator>
    <multiInstitutionIndicator>true</multiInstitutionIndicator>
    <randomizedIndicator>true</randomizedIndicator>
    <shortTitleText>
        Gemcitabine and Docetaxel With Or Without Bevacizumab in
        Leiomyosarcoma, Malignant Fibrous Histiocytoma and Angiosarcoma
    </shortTitleText>
    <longTitleText>
        Gemcitabine and Docetaxel With Or Without Bevacizumab in
        Leiomyosarcoma, Malignant Fibrous Histiocytoma and Angiosarcoma
    </longTitleText>
    <descriptionText>
        The purpose of this study is to test whether an experimental
        drug called bevacizumab given together with gemcitabine and
        docetaxel, a standard chemotherapy regimen for sarcoma, can help
        sarcoma patients. This trial will compare gemcitabine,
        docetaxeland bevacizumab with gemcitabine and docetaxel alone.
        The investigators want to find out whether bevacizumab given
        with gemcitabine and docetaxel is better than gemcitabine and
        docetaxel alone as treatment for sarcoma.
    </descriptionText>
    <precisText />
    <phaseCode>Phase II/III Trial</phaseCode>
    <coordinatingCenterStudyStatus>
        ACTIVE
    </coordinatingCenterStudyStatus>
    <type>N/A</type>
    <targetAccrualNumber>10</targetAccrualNumber>
    <identifier xsi:type="OrganizationAssignedIdentifierType">
        <type>Coordinating Center Identifier</type>
        <value>NCI-2009-00008</value>
        <primaryIndicator>true</primaryIndicator>
        <healthcareSite>
            <name>National Cancer Institute</name>
            <address>
                <streetAddress>6116 Executive Boulevard</streetAddress>
                <city>Bethesda</city>
                <stateCode>MD</stateCode>
                <postalCode>20892</postalCode>
                <countryCode>USA</countryCode>
            </address>
            <nciInstituteCode>NCI</nciInstituteCode>
        </healthcareSite>
    </identifier>
    <identifier xsi:type="SystemAssignedIdentifierType">
        <type>COPPA Identifier</type>
        <value>27656</value>
        <systemName>COPPA</systemName>
    </identifier>
    <epoch xsi:type="TreatmentEpochType"
        gridId="15033d3d-6e08-4e08-85b7-42b92a54a5ef">
        <name>Epoch 1</name>
        <descriptionText />
        <arm gridId="09f0c44e-ff3e-4b8c-964b-11893d2cd7f2">
            <name>Arm A</name>
            <descriptionText />
        </arm>
        <arm gridId="73fbf6a5-3595-40e3-8ae6-b2c6a100ce2f">
            <name>Arm B</name>
            <descriptionText />
        </arm>
    </epoch>
    <studyOrganization xsi:type="StudyCoordinatingCenterType">
        <healthcareSite>
            <name>Maricopa Medical Center</name>
            <address>
                <city>Phoenix</city>
                <stateCode>AZ</stateCode>
                <countryCode>USA</countryCode>
            </address>
            <nciInstituteCode>AZ005</nciInstituteCode>
        </healthcareSite>
        <studyInvestigator>
            <roleCode>Principal Investigator</roleCode>
            <statusCode>AC</statusCode>
            <healthcareSiteInvestigator>
                <investigator>
                    <nciIdentifier>164997</nciIdentifier>
                    <fullName>Kathleen Loviscek</fullName>
                </investigator>
            </healthcareSiteInvestigator>
        </studyInvestigator>
    </studyOrganization>
    <studyOrganization xsi:type="StudyFundingSponsorType">
        <healthcareSite>
            <name>Louisiana State University Medical Center CCOP</name>
            <address>
                <city>New Orleans</city>
                <stateCode>LA</stateCode>
                <countryCode>USA</countryCode>
            </address>
            <nciInstituteCode>LA047</nciInstituteCode>
        </healthcareSite>
    </studyOrganization>
    <studyOrganization xsi:type="StudySiteType">
        <healthcareSite>
            <name>San Francisco General</name>
            <address>
                <city>San Francisco</city>
                <stateCode>CA</stateCode>
                <countryCode>USA</countryCode>
            </address>
            <nciInstituteCode>CA125</nciInstituteCode>
        </healthcareSite>
        <studyInvestigator>
            <roleCode>Site Investigator</roleCode>
            <statusCode>AC</statusCode>
            <healthcareSiteInvestigator>
                <investigator>
                    <nciIdentifier>146122</nciIdentifier>
                    <fullName>Sidney Pinkus</fullName>
                </investigator>
            </healthcareSiteInvestigator>
        </studyInvestigator>
        <siteStudyStatus>ACTIVE</siteStudyStatus>
    </studyOrganization>
</study>